Consistent EBITDA Growth
The third quarter of 2024 marks the fifth consecutive quarter of EBITDA growth, with adjusted EBITDA growing 6.2% year-over-year to $7.8 million and a margin increase of 60 basis points to 8.4%.
Debt Reduction and Financial Flexibility
Net debt was reduced by $8.5 million to $38.3 million compared to the previous quarter, with a net debt to annualized run rate adjusted EBITDA ratio of 1.2x, down from 1.6x.
New Fulfillment Center
CareRx announced the opening of a new high-volume fulfillment center in North Burnaby, British Columbia, enhancing service delivery and employee experience.
Pipeline Growth and Secured Beds
CareRx has secured almost 3,000 beds for the next year, with expectations for growth as the regulatory approvals are processed.